Abridge
Applications · US
Abridge was valued at $5.3B as of 23 June 2025 (verified). Source: Abridge secures a $300M Series E led by a16z, with Khosla Ventures, at a $5.3B valuation (company blog).
Ambient clinical documentation; converts patient visits into structured notes.
- Valuation
- $5.3B
- Confidence
- verified
- As of
- 23 June 2025
- Layer
- Applications
- Signal
- clinical notes
- Website
- abridge.com
Relationships (2)
Abridge routes to
- Anthropicunsourced
Sources
- Abridge secures a $300M Series E led by a16z, with Khosla Ventures, at a $5.3B valuation (company blog) 2025-06-23
- Modern Healthcare, Abridge raises $300M in Series E funding led by a16z 2025-06-23
See something wrong or out of date? Suggest a correction (GitHub) or email it. Please include a source.
Last updated 23 June 2025. Follow Abridge in any feed reader to hear when its valuation moves.
State of AI World maps every significant AI company, what it is worth and how it is connected. Every number carries a source and an as-of date; see the methodology. Data is free to reuse with credit: open data. · All companies · Daily digest · Corrections and contact